Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo.
Ulges A, Klein M, Reuter S, Gerlitzki B, Hoffmann M, Grebe N, Staudt V, Stergiou N, Bohn T, Brühl TJ, Muth S, Yurugi H, Rajalingam K, Bellinghausen I, Tuettenberg A, Hahn S, Reißig S, Haben I, Zipp F, Waisman A, Probst HC, Beilhack A, Buchou T, Filhol-Cochet O, Boldyreff B, Breloer M, Jonuleit H, Schild H, Schmitt E, Bopp T. Ulges A, et al. Among authors: rajalingam k. Nat Immunol. 2015 Mar;16(3):267-75. doi: 10.1038/ni.3083. Epub 2015 Jan 19. Nat Immunol. 2015. PMID: 25599562
Ubiquitin-dependent regulation of Cdc42 by XIAP.
Murali A, Shin J, Yurugi H, Krishnan A, Akutsu M, Carpy A, Macek B, Rajalingam K. Murali A, et al. Among authors: rajalingam k. Cell Death Dis. 2017 Jun 29;8(6):e2900. doi: 10.1038/cddis.2017.305. Cell Death Dis. 2017. PMID: 28661476 Free PMC article.
Targeting prohibitins at the cell surface prevents Th17-mediated autoimmunity.
Buehler U, Schulenburg K, Yurugi H, Šolman M, Abankwa D, Ulges A, Tenzer S, Bopp T, Thiede B, Zipp F, Rajalingam K. Buehler U, et al. Among authors: rajalingam k. EMBO J. 2018 Aug 15;37(16):e99429. doi: 10.15252/embj.201899429. Epub 2018 Jul 26. EMBO J. 2018. PMID: 30049713 Free PMC article.
ERK3/MAPK6 controls IL-8 production and chemotaxis.
Bogucka K, Pompaiah M, Marini F, Binder H, Harms G, Kaulich M, Klein M, Michel C, Radsak MP, Rosigkeit S, Grimminger P, Schild H, Rajalingam K. Bogucka K, et al. Among authors: rajalingam k. Elife. 2020 Apr 21;9:e52511. doi: 10.7554/eLife.52511. Elife. 2020. PMID: 32314963 Free PMC article.
ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.
Bogucka K, Marini F, Rosigkeit S, Schloeder J, Jonuleit H, David K, Schlackow M, Rajalingam K. Bogucka K, et al. Among authors: rajalingam k. Cancer Gene Ther. 2021 May;28(5):359-374. doi: 10.1038/s41417-020-00245-w. Epub 2020 Oct 17. Cancer Gene Ther. 2021. PMID: 33070159
Correction: ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.
Bogucka K, Marini F, Rosigkeit S, Schloeder J, Jonuleit H, David K, Schlackow M, Rajalingam K. Bogucka K, et al. Among authors: rajalingam k. Cancer Gene Ther. 2021 May;28(5):543. doi: 10.1038/s41417-020-00250-z. Cancer Gene Ther. 2021. PMID: 33168935 No abstract available.
ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppression.
Riegel K, Yurugi H, Schlöder J, Jonuleit H, Kaulich M, Kirschner F, Arnold-Schild D, Tenzer S, Schild H, Rajalingam K. Riegel K, et al. Among authors: rajalingam k. Cell Death Dis. 2021 Oct 20;12(11):969. doi: 10.1038/s41419-021-04257-8. Cell Death Dis. 2021. PMID: 34671021 Free PMC article.
126 results